The "active discussions" were wrt combination trials. That is far different than partnership.
And NWBO has disclosed many of these in the past. About 8 years ago there was the announcement of discussions for 3 trials with 3 companies. And none launched.
Neither of the 2 current combo trials discussed involve NWBO. They are both UCLA studies of generic ATL DC.